BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34706754)

  • 1. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review.
    Daniele A; Divella R; Pilato B; Tommasi S; Pasanisi P; Patruno M; Digennaro M; Minoia C; Dellino M; Pisconti S; Casamassima P; Savino E; Paradiso AV
    Hered Cancer Clin Pract; 2021 Oct; 19(1):45. PubMed ID: 34706754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.
    Grill S; Yahiaoui-Doktor M; Dukatz R; Lammert J; Ullrich M; Engel C; Pfeifer K; Basrai M; Siniatchkin M; Schmidt T; Weisser B; Rhiem K; Ditsch N; Schmutzler R; Bischoff SC; Halle M; Kiechle M
    Arch Gynecol Obstet; 2017 Dec; 296(6):1135-1144. PubMed ID: 28975393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.
    van Erkelens A; Derks L; Sie AS; Egbers L; Woldringh G; Prins JB; Manders P; Hoogerbrugge N
    J Genet Couns; 2017 Aug; 26(4):785-791. PubMed ID: 27966054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
    Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
    Trials; 2016 Jul; 17():368. PubMed ID: 27473440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
    Nkondjock A; Robidoux A; Paredes Y; Narod SA; Ghadirian P
    Breast Cancer Res Treat; 2006 Aug; 98(3):285-94. PubMed ID: 16541324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations.
    Bissonauth V; Shatenstein B; Fafard E; Maugard C; Robidoux A; Narod S; Ghadirian P
    J Cancer Epidemiol; 2009; 2009():748367. PubMed ID: 20445803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review.
    Huber D; Seitz S; Kast K; Emons G; Ortmann O
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2035-2045. PubMed ID: 33885953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.
    Pettapiece-Phillips R; Narod SA; Kotsopoulos J
    Cancer Causes Control; 2015 Mar; 26(3):333-44. PubMed ID: 25579073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
    Valachis A; Nearchou AD; Lind P
    Breast Cancer Res Treat; 2014 Apr; 144(3):443-55. PubMed ID: 24567198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
    Evron E; Ben-David AM; Goldberg H; Fried G; Kaufman B; Catane R; Pfeffer MR; Geffen DB; Chernobelsky P; Karni T; Abdah-Bortnyak R; Rosengarten O; Matceyevsky D; Inbar M; Kuten A; Corn BW
    Ann Oncol; 2019 Mar; 30(3):412-417. PubMed ID: 30475942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Profiling Comparison of Germline
    Huang X; Shao D; Wu H; Zhu C; Guo D; Zhou Y; Chen C; Lin Y; Lu T; Zhao B; Wang C; Sun Q
    Front Oncol; 2020; 10():583314. PubMed ID: 33194720
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.
    Primas H; Kroiss R; Kalteis K; Rappaport C; Muhr D; Primas C; Kubista E; Horvat R; Oefner P; Singer C; Wagner And The Austrian Hereditary Breast And Ovarian Cancer Group T
    Eur J Cancer Prev; 2012 Mar; 21(2):199-204. PubMed ID: 22252303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
    Kim SJ; Huzarski T; Gronwald J; Singer CF; Møller P; Lynch HT; Armel S; Karlan BY; Foulkes WD; Neuhausen SL; Senter L; Eisen A; Eng C; Panchal S; Pal T; Olopade O; Zakalik D; Lubinski J; Narod SA; Kotsopoulos J;
    Int J Epidemiol; 2018 Jun; 47(3):987-997. PubMed ID: 29547931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
    Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
    Grindedal EM; Heramb C; Karsrud I; Ariansen SL; Mæhle L; Undlien DE; Norum J; Schlichting E
    BMC Cancer; 2017 Jun; 17(1):438. PubMed ID: 28637432
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.